E-viri
Recenzirano
-
Greer, Lisa; Landwehr, Karen
Journal for nurse practitioners, 04/2013, Letnik: 9, Številka: 4Journal Article
The major difficulties with diabetic treatment root in self-management, patient tolerance, and compliance with treatments. A new medication class, glucagon-like peptide-1 (GLP-1) analogs, has evidence of combining weight loss and glucose control with minimal side effects and cardiovascular benefit. For years, the standard therapy was adding insulin for patients with suboptimal response to oral agents. This method takes advanced education and lifestyle modifications to elicit adequate response. New injectable options allow initiation of a simpler regimen. The focus of this systematic review is to evaluate available evidence about the effect of GLP-1 analog therapy on patient compliance and quality of life.
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|
Vir: Osebne bibliografije
in: SICRIS
To gradivo vam je dostopno v celotnem besedilu. Če kljub temu želite naročiti gradivo, kliknite gumb Nadaljuj.